Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shell
SHEL
|
+$972M |
| 2 |
Meta Platforms (Facebook)
META
|
+$324M |
| 3 |
Webster Financial
WBS
|
+$279M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Advanced Micro Devices
AMD
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$780M |
| 2 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$335M |
| 3 |
STL
Sterling Bancorp
STL
|
+$283M |
| 4 |
SC
SANTANDER CONSUMER USA HOLDINGS INC
SC
|
+$252M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$241M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.89% |
| 2 | Technology | 16.14% |
| 3 | Industrials | 12.35% |
| 4 | Healthcare | 10.84% |
| 5 | Consumer Discretionary | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
DiaMedica Therapeutics
DMAC
$351M
| $145K | ﹤0.01% |
58,015
+46,115
| +388% | +$131K |
|
|
AHPI
3352
DELISTED
Allied Healthcare Products
AHPI
| $143K | ﹤0.01% |
44,137
+1,274
| +3% | +$4.49K |
|
|
BNBX
3353
DELISTED
BNB PLUS CORP
BNBX
| $141K | ﹤0.01% |
4
+1
| +33% | +$44.8K |
|
3354
Alphatec Holdings
ATEC
$1.49B
| $140K | ﹤0.01% |
12,199
-16,260
| -57% | -$176K |
|
3355
Actinium Pharmaceuticals
ATNM
$26.3M
| $140K | ﹤0.01% |
27,304
+1,195
| +5% | +$6.29K |
|
|
LITS
3356
Lite Strategy Inc
LITS
$33.6M
| $140K | ﹤0.01% |
11,636
-2,263
| -16% | -$88.9K |
|
|
AVEO
3357
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $140K | ﹤0.01% |
25,027
+200
| +0.8% | +$824 |
|
|
TULP
3358
Bloomia Holdings
TULP
$15.6M
| $138K | ﹤0.01% |
+12,204
| New | +$154K |
|
3359
Jerash Holdings
JRSH
$58.4M
| $136K | ﹤0.01% |
21,239
+128
| +0.6% | +$855 |
|
|
WPRT
3360
Westport Fuel Systems
WPRT
$32.7M
| $136K | ﹤0.01% |
8,589
+96
| +1% | +$1.72K |
|
3361
MediciNova
MNOV
$66M
| $135K | ﹤0.01% |
50,574
-4,281
| -8% | -$10.5K |
|
3362
Aehr Test Systems
AEHR
$2.51B
| $134K | ﹤0.01% |
13,183
-54,875
| -81% | -$702K |
|
|
LGO
3363
Largo
LGO
$59.4M
| $134K | ﹤0.01% |
10,534
+424
| +4% | +$4.39K |
|
3364
Savara
SVRA
$1.14B
| $133K | ﹤0.01% |
101,550
-5,735
| -5% | -$6.91K |
|
|
BGMS
3365
Bio Green Med Solution Inc
BGMS
$5.04M
| $132K | ﹤0.01% |
12
| – | – |
|
3366
Turkcell
TKC
$4.72B
| $132K | ﹤0.01% |
33,805
| – | – |
|
3367
Lifestance Health
LFST
$4.1B
| $130K | ﹤0.01% |
+12,826
| New | +$113K |
|
3368
Virgin Galactic
SPCE
$329M
| $128K | ﹤0.01% |
646
-3,377
| -84% | -$631K |
|
|
SIOX
3369
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $128K | ﹤0.01% |
190,670
-362,064
| -66% | -$307K |
|
3370
QuickLogic
QUIK
$228M
| $125K | ﹤0.01% |
22,660
| – | – |
|
|
TUEM
3371
DELISTED
Tuesday Morning Corp
TUEM
| $125K | ﹤0.01% |
3,803
-986
| -21% | -$47.5K |
|
|
CODX
3372
Co-Diagnostics
CODX
$5.75M
| $124K | ﹤0.01% |
671
-2
| -0.3% | -$414 |
|
|
RVLP
3373
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $123K | ﹤0.01% |
72,623
| – | – |
|
|
TBHC
3374
DELISTED
The Brand House Collective
TBHC
| $121K | ﹤0.01% |
13,016
| – | – |
|
|
ZYXI
3375
DELISTED
Zynex
ZYXI
| $120K | ﹤0.01% |
19,317
-3
| -0% | -$21 |
|
Similar funds
Dimensional Fund Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, Dimensional Fund Advisors held 3,635 positions worth $325B, down 1.9% from $331B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dimensional Fund Advisors's Q1 2022 filing shows 98 new, 2,062 increased, 1,167 reduced and 121 closed positions. Its largest new stake was Shell: 18,315,111 shares worth $1.01B. The largest sale was Royal Dutch Shell PLC ADS Class B, an estimated $780M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Industrials.
- Dimensional Fund Advisors's largest Q1 2022 buy was Shell: 18,315,111 shares worth $1.01B.
- Dimensional Fund Advisors added most to Meta Platforms (Facebook) in Q1 2022, an estimated $324M increase.
- Dimensional Fund Advisors's biggest Q1 2022 reduction was Canadian Pacific Kansas City, cutting an estimated $241M.
- Dimensional Fund Advisors fully exited Royal Dutch Shell PLC ADS Class B in Q1 2022, selling an estimated $780M.
- Dimensional Fund Advisors's ten largest holdings make up 11% of its $325B portfolio in Q1 2022.
- Dimensional Fund Advisors opened 98 new positions and closed 121 in Q1 2022.
- Dimensional Fund Advisors's portfolio value fell 1.9% quarter-over-quarter to $325B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2022, filed 13 May 2022.